Manning; James R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Manning; James R..The latest application filed is for "fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections".

Company Profile

5.8.15

Manning; James R. - Pleasant Hill CA
MANNING; James R. - Emeryville CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tricyclic compounds useful to treat orthomyxovirus infections Grant 11,453,677 - Jain , et al. September 27, 2	2022-09-27
Fused Tricyclic Pyridazinone Compounds Useful to Treat Orthomyxovirus Infections App 20220041610 - JAIN; Rama ; et al.	2022-02-10
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections Grant 11,098,051 - Jain , et al. August 24, 2	2021-08-24
Novel Dihydroisoxazole Compounds And Their Use For The Treatment Of Hepatitis B App 20210079015 - FU; Jiping ; et al.	2021-03-18
10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione Derivatives And Related Compounds As Inhibitors Of The Orthomyxovirus Replication For Treating Influenza App 20200407366 - DAUPHINAIS; Maxime ; et al.	2020-12-31
Indole-2-carbonyl Compounds And Their Use For The Treatment Of Hepatitis B App 20200407365 - FU; Jiping ; et al.	2020-12-31
Tricyclic compounds useful to treat orthomyxovirus infections Grant 10,858,366 - Jain , et al. December 8, 2	2020-12-08
Tricyclic Compounds Useful to Treat Orthomyxovirus Infections App 20200347072 - JAIN; Rama ; et al.	2020-11-05
Fused Tricyclic Pyridazinone Compounds Useful To Treat Orthomyxovirus Infections App 20200123167 - JAIN; Rama ; et al.	2020-04-23
Tricyclic Compounds Useful To Treat Orthomyxovirus Infections App 20190092780 - JAIN; Rama ; et al.	2019-03-28
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections Grant 10,160,764 - Jain , et al. Dec	2018-12-25
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Grant 10,112,931 - Caferro , et al. October 30, 2	2018-10-30
Fused Tricyclic Pyridazinone Compounds Useful To Treat Orthomyxovirus Infections App 20180057501 - JAIN; Rama ; et al.	2018-03-01
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20180051015 - CAFERRO; Thomas Raymond ; et al.	2018-02-22
Cyclopropyl Fused Thiazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use App 20170267673 - ALLEN; Jennifer R. ; et al.	2017-09-21
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Grant 9,688,672 - Caferro , et al. June 27, 2	2017-06-27
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20160318915 - CAFERRO; Thomas Raymond ; et al.	2016-11-03
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Grant 9,434,719 - Caferro , et al. September 6, 2	2016-09-06
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20150152093 - Caferro; Thomas Raymond ; et al.	2015-06-04
3-pyrimidin-4-yl-oxazolidin-2-ones As Inhibitors Of Mutant Idh App 20140275083 - CAFERRO; Thomas Raymond ; et al.	2014-09-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.